BL 1889
Latest Information Update: 17 Nov 2003
At a glance
- Originator Rodlen Laboratories
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pruritus
Most Recent Events
- 04 Dec 2002 unspecified for Pruritus in United Kingdom (unspecified route)
- 05 Dec 2001 Preclinical development for Pruritus in United Kingdom (Unknown route)